Keryx Biopharm Inc (KERX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2004 | 09-2004 | 06-2004 | 03-2004 | 12-2003 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -32,943 | -28,335 | -25,082 | -21,823 | -9,108 |
| Depreciation Amortization | 155 | 116 | 76 | 35 | 940 |
| Income taxes - deferred | N/A | N/A | N/A | N/A | 102 |
| Other Working Capital | 487 | -956 | -743 | -399 | -1,511 |
| Other Operating Activity | 20,297 | 20,059 | 19,831 | 19,187 | 2,283 |
| Operating Cash Flow | $-12,004 | $-9,116 | $-5,918 | $-3,000 | $-7,294 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -10,404 | -6,048 | -784 | 1,798 | 944 |
| PPE Investments | -24 | -18 | -7 | -7 | 384 |
| Purchase Of Investment | N/A | N/A | -5,044 | -5,053 | N/A |
| Sale Of Investment | N/A | N/A | N/A | N/A | 416 |
| Other Investing Activity | -12 | -8 | -4 | -4 | -417 |
| Investing Cash Flow | $-10,440 | $-6,074 | $-5,839 | $-3,266 | $1,327 |
| Cash Flows From Financing Activities | |||||
| Debt Repayment | -6,322 | -6,322 | -6,322 | -6,322 | N/A |
| Common Stock Issued | 36,696 | 35,433 | 34,759 | 33,930 | 14,314 |
| Common Stock Repurchased | N/A | N/A | N/A | N/A | -12 |
| Financing Cash Flow | $30,374 | $29,111 | $28,437 | $27,608 | $14,302 |
| Exchange Rate Effect | 3 | 3 | N/A | N/A | -13 |
| Beginning Cash Position | 21,672 | 21,672 | 21,672 | 21,672 | 13,350 |
| End Cash Position | 29,699 | 35,690 | 38,446 | 43,108 | 21,672 |
| Net Cash Flow | $8,027 | $14,018 | $16,774 | $21,436 | $8,322 |
| Free Cash Flow | |||||
| Operating Cash Flow | -12,004 | -9,116 | -5,918 | -3,000 | -7,294 |
| Capital Expenditure | -24 | -18 | -7 | -7 | -3 |
| Free Cash Flow | -12,028 | -9,134 | -5,925 | -3,007 | -7,297 |